Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,116

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,793

Class I recallsReasonable probability of serious health consequences

24,343

Class II recallsTemporary or medically reversible health consequences

2,887

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/saratoga-potato-chips-issues-allergy-alert-undeclared-soy-j-higgs-loaded-bacon-and-cheddar-potatoPublished September 16, 2026

Most affected stateHawaii 200 recalls mention this state

State: ND ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 18, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

FDA Recall Terminated Historical recordClass II

Droperidol Injectable Sterile Solution, 0.625mg/mL, 1mL in a 3mL Sterile Single-Use Syringe, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-185-10, barcode 0 69623 18510 5.

by Premier Pharmacy Labs Inc

Reason: Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Published: July 3, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ChlorproMAZINE HCL INJ, 25mg/mL, Contains Sulfites, 1mL in a 5mL Sterile SDV, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-122-28, barcode 7 69623 12228 4.

by Premier Pharmacy Labs Inc

Reason: Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Published: July 3, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Brilliant Blue Ophthalmic PF INJ, 0.5mg/mL (0.05%), 1 mL SDV, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-211-31, barcode 2 69623 21131 0.

by Premier Pharmacy Labs Inc

Reason: Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Published: July 3, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atropine Sulfate PF INJ, 0.8 mg/2 mL (0.4 mg/mL), 2mL Single Dose Syringe, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-131-12, barcode 0 69623 13112 6.

by Premier Pharmacy Labs Inc

Reason: Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Published: July 3, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

MethylPREDNISolone Tablets, USP 8 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-917-11

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochloride Tablets 1.5 mg 90-count bottle, Rx only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ NDC 68382-200-16

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

MethylPREDNISolone Tablets, USP 32 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-919-11

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

MethylPREDNISolone Tablets, USP 16 mg, 50 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-918-18

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

MethylPREDNISolone Tablets, USP 4 mg per tablet, 21 Tablets dosepack, Rx Only, Made in India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-916-34

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

MethylPREDNISolone Tablets, USP, 4 mg, 100 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India NDC 68382-916-01

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochloride Tablets 1 mg, 90-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-199-16

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochloride Tablets 0.5 mg, 90-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-198-16

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochloride Tablets 0.25 mg, 1000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. NDC 68382-197-10

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochoride Tablets 0.25 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-197-16

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole DihydrochlorideTablets 0.125 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-16

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochloride Tablets 0.125 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-10

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Anastrozole Tablets, USP, 1 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534. NDC 68382-209-10

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ANASTROZOLE Tablets, 1 mg, Rx Only, 30-count bottle, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534 NDC 68382-209-06

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cetirizine Oral Solution 1 mg/mL, Up & Up, Children's allergy relief, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. (118 mL) Bottle, Distributed by Target Corporation, Minneapolis, MN 55403, NDC 11673-178-04, UPC 359726178044.

by P & L Developments, LLC

Reason: cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cetirizine Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. Bottle, Distributed by C.D.M.A. Inc., Novi, MI 48376, Quality Choice, NDC 63868-430-04, UPC 635515992474.

by P & L Developments, LLC

Reason: cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Published: June 26, 2019
Distribution: Nationwide

View recall →

Data last updated: September 18, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.